Over the last 15 years, we have accumulated invaluable specific experience in drug discovery in the ubiquitin-proteasome system. Our work includes diverse modalities such as Degraders, GLUTACs, E3 binders, E3 inhibitors, small molecules, combination..
Relevance: 11.871216